Can Soleno Therapeutics (SLNO) Climb 33.11% to Reach the Level Wall Street Analysts Expect?

Group 1 - Soleno Therapeutics, Inc. (SLNO) shares have increased by 2.2% over the past four weeks, closing at $86.02, with a mean price target of $114.5 indicating a potential upside of 33.1% [1] - The average price targets from analysts range from a low of $97.00 to a high of $145.00, with a standard deviation of $15.46, suggesting a variability in estimates [2] - Analysts show strong agreement on SLNO's ability to report better earnings than previously predicted, which supports the potential for stock upside [4][11] Group 2 - The Zacks Consensus Estimate for SLNO's current year earnings has increased by 25.8% over the past month, with three estimates revised higher and no negative revisions [12] - SLNO holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting the extent of gains, they can provide a directional guide for price movement [14]